The phytocannabinoid, Δ9‐tetrahydrocannabivarin, can act through 5‐HT1A receptors to produce antipsychotic effects
This study tested the cannabis-related compound THCV in lab and rat experiments. In lab tests on rat brain membranes and human cells, 100 nM THCV increased activation of the serotonin 5-HT1A receptor and changed how a 5-HT1A probe bound to the receptor. In rats treated with phencyclidine (a model for…